Current Report Filing (8-k)
July 25 2022 - 03:16PM
Edgar (US Regulatory)
0001550020 false 0001550020 2022-07-22
2022-07-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(D) of The Securities Exchange Act of
1934
Date
of Report (Date of earliest event reported):
July 22, 2022
eWELLNESS HEALTHCARE CORPORATION
(Exact
name of registrant as specified in its charter)
|
Nevada |
|
000-55203 |
|
90-1073143 |
|
(State
or other jurisdiction
of
Incorporation)
|
|
(Commission
File
Number
|
|
(IRS
Employer
identification
Number
|
eWellness Healthcare Corporation
1126 S Federal Highway #464
Ft. Lauderdale
FL
33316
(Address
of principal executive offices)
Registrant’s
Telephone Number, including area code: (855)
470-1700
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the Company under
any of the following provisions:
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
| |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
| |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None
|
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging
growth company
☒
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
Item
5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On July 22. 2022 at 10:00 a.m., the following directors and
officers of eWellness Healthcare Corporation (the Company) resigned
any and all positions with the Company, including: Douglas
MacLellan, Chairman and CEO, David Markowski, CFO and Director, and
Doug Cole, Director. Over the past year the Company has continued
to operate through advances provided by certain shareholders. Due
to the current economic conditions, these shareholders are
unwilling to continue to fund the Company, leaving the Company with
no financial resources to continue paying bills as they come due,
including professional fees related to public filings under the
Securities Exchange Act of 1934, paying for administrative fees and
expenses and/or working to complete various merger transactions.
None of these directors or officers indicated any disagreements
with the Company on any matter relating to its operations, policies
or practices. Their respective letters of resignation are attached
as Exhibits to this Form 8-K.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
| Date: July 25, 2022 |
By: |
/s/
Douglas MacLellan |
| |
Name: |
Douglas
MacLellan |
| |
Title: |
Chairman
of the Board and CEO |
eWellness Healthcare (CE) (USOTC:EWLL)
Historical Stock Chart
From Jan 2023 to Feb 2023
eWellness Healthcare (CE) (USOTC:EWLL)
Historical Stock Chart
From Feb 2022 to Feb 2023
